SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: jopawa who wrote (748)12/10/1998 1:42:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 2539
 
Interesting article. Thanks, John. I like their mentioning whether the brokerage's done any underwriting for Merck when quoting their comments.



To: jopawa who wrote (748)12/10/1998 1:52:00 PM
From: SteveR  Read Replies (2) | Respond to of 2539
 
Did anyone pick up on a bit of an error in the Merck 'Bet Against Us and You'll Feel the Pain' story?

> One major New York health-care investor who is long Merck says, >"They're so comfortable, they're doing head-to-head studies. That
>tells you they have a real advantage. It might have a nice aura
>effect" in the marketing of the drugs.

Excuse me? I didn't know Celebrex was available to competitors for comparison studies.

stever


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News